Search

everythinglearnresearchcommunity

for

Search:↓

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

The combination therapy was effective and well-tolerated, especially in young patients.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Tocilizumab might be an effective treatment for COVID-19.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

CTP-543 is generally safe for treating alopecia areata.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Liposomal adapalene improves delivery to hair follicles and reduces side effects for acne treatment.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Rituximab can cause skin issues, but baricitinib may help improve them.

Upadacitinib effectively treated severe hair loss in a child.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.